Inhalis
Lugano, CH · 1 known investors
Find your way into Inhalis
Sign up to see every warm intro you have to Inhalis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inhalis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.
Investors · 1
Frequently asked questions
- What does Inhalis do?
- Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.
- Who are Inhalis's investors?
- Inhalis's investors include TiVenture SA.
- Where is Inhalis headquartered?
- Inhalis is headquartered in Lugano, CH.
